Delavirdine Mesylate Patent Expiration
Delavirdine Mesylate was first introduced by Viiv Healthcare Co
Delavirdine Mesylate Patents
Given below is the list of patents protecting Delavirdine Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rescriptor | US5563142 | Diaromatic substituted compounds as anti-HIV-1 agents |
Oct 08, 2013
(Expired) | Viiv Hlthcare |
| Rescriptor | US6177101 | Delavirdine high strength tablet formulation |
Jun 07, 2019
(Expired) | Viiv Hlthcare |